Valye reports for unlimited access

Northern Trust Corporation is a financial services firm with diversified operations including wealth management, asset servicing, investment management, securities lending, and other trust-related services. The company’s 2025 annual report and Q1 2026 quarterly report provide detailed financial and operational disclosures. Northern Trust serves institutional and individual clients, managing assets and providing fiduciary and banking services.

Tenet Healthcare Corporation is a large, diversified healthcare services company headquartered in Dallas, Texas, with a Global Business Center in the Philippines. The company operates through two primary segments: Hospital Operations and Ambulatory Care. The Hospital Operations segment includes 50 acute care and specialty hospitals, a network of employed physicians, and 132 outpatient facilities such as urgent care centers and imaging centers. The Ambulatory Care segment, operated through USPI Holding Company, includes ownership interests in 533 ambulatory surgery centers and 26 surgical hospitals across 37 states. Tenet also provides revenue cycle management and value-based care services through Conifer Health Solutions, which it fully owns as of January 2026. The company employs approximately 99,000 people and operates in a complex regulatory environment. Financially, Tenet reported strong liquidity and earnings metrics as of Q1 2026.

Apollo Commercial Real Estate Finance, Inc. is a Maryland corporation and a REIT that primarily originates, acquires, invests in, and manages performing commercial first mortgage loans, subordinate financings, and other commercial real estate-related debt investments. The company is externally managed by a subsidiary of Apollo Global Management, leveraging Apollo's global platform and expertise. ARI sold its commercial real estate loan portfolio to Athene for approximately $8.6 billion. The company maintains a leveraged capital structure and actively manages its portfolio with a dedicated asset management team. ARI adheres to investment guidelines designed to maintain REIT qualification and limit concentration risk. The company generates income primarily from interest on its loan portfolio and related real estate owned operations.

Air Lease Corp operates in the aircraft leasing industry, managing a capital-intensive business model with a focus on leasing commercial aircraft to airline customers globally. The company completed a significant merger in April 2026, becoming an indirect subsidiary of Sumisho Air Lease Corporation, jointly owned by Sumitomo Corporation, SMBC Aviation Capital, Apollo managed funds, and Brookfield. The merger resulted in changes to the board of directors and executive leadership, with Noriyuki Hiruta appointed as CEO. The company’s business involves acquiring, leasing, and managing aircraft fleets, including recent deliveries of Boeing 737-8 aircraft to customers such as Air Canada. The company reported FY 2025 revenues of approximately $3.02 billion and net income of approximately $1.09 billion. The company’s stock was delisted from the NYSE following the merger. The company announced a workforce reduction plan post-merger affecting 40% of employees, with severance and benefits provided. Executive compensation is structured around pay-for-performance principles tied to financial and operational metrics. The company faces typical risks related to merger completion, regulatory approvals, and integration.

Talkspace, Inc. operates in the mental health services sector, offering innovative and personalized care solutions. The company has a management team led by CEO Jon Cohen and CFO Ian Harris. Talkspace has pursued growth through acquisitions, including Wisdo Health, and marketing campaigns aimed at increasing user engagement. The company reported revenues of $27.6 million for fiscal year 2024 and net income of $7.793 million for fiscal year 2025. In March 2026, Talkspace entered into a merger agreement to be acquired by Universal Health Services, Inc., subject to stockholder and regulatory approvals. The merger is expected to result in the company becoming a wholly owned subsidiary of Universal Health Services and delisting from Nasdaq.

NEXGEL, INC. operates in the regenerative biomaterials sector, focusing on commercial-stage and development-stage biomaterial products. The company completed an asset purchase and exclusive license agreement with Celularity, Inc. in early 2026, acquiring rights to six biomaterial products and related assets. The transaction includes upfront and milestone payments, with an amended total consideration of $13.3 million. NEXGEL has a convertible note facility providing capital with secured interests in company assets. The company reported significant revenue growth in 2024 and early 2025, reflecting expansion in its product offerings and partnerships, including with STADA Arzneimittel AG. The company is publicly traded on Nasdaq under the ticker NXGL but has received a deficiency notice due to its stock price falling below the minimum bid price requirement. Management changes include the appointment of Ian Blackman as CFO in April 2026. Financially, the company reported a net loss for 2025 but maintains liquidity with a current ratio of 1.47 as of year-end 2025.

Cambium Networks Corp is a global provider of wireless broadband networking infrastructure products and services, operating primarily through its subsidiary Cambium Networks, Ltd. The company employs approximately 486 full-time employees worldwide, with a significant portion located outside the United States. It outsources manufacturing to third-party manufacturers predominantly outside the U.S., relying on distribution hubs in the U.S., Netherlands, and Vietnam to fulfill worldwide sales. Sales are primarily conducted through distributors and value-added resellers, with a concentration of revenues from a few key distributors. The company faces operational challenges including supply chain disruptions, component shortages, and quality control issues. Cambium Networks has experienced fluctuations in operating results due to the timing and size of sales orders and seasonal demand variations. The company has been delisted from Nasdaq and now trades on the OTC Expert Market, resulting in reduced liquidity and market visibility. Financially, the company reported a net loss and negative earnings per share for the fiscal year ended December 31, 2025, with liquidity constraints reflected in a current ratio below 1.0. The company is engaged in cost reduction efforts and working with lenders to address defaults under its secured Credit Agreement. It also faces risks related to intellectual property claims, cybersecurity, regulatory compliance, and international operations.

Cambium Networks Corp is a global provider of wireless broadband solutions, operating through its subsidiary Cambium Networks, Ltd. The company designs and sells wireless networking products primarily through distributors and channel partners worldwide, with significant international revenue exposure. Manufacturing is outsourced to third-party manufacturers mainly located outside the US, including Vietnam and Thailand. The company emphasizes innovation and integrity in its corporate culture and maintains a global workforce of approximately 486 employees as of end 2025. Cambium Networks faces operational risks related to supply chain dependencies, distributor concentration, and long sales cycles. Financially, the company reported a net loss and negative earnings per share for fiscal 2025, with liquidity challenges and noncompliance with credit covenants leading to delisting from Nasdaq and trading on OTC markets [S1].

Cambium Networks Corp, through its subsidiary Cambium Networks, Ltd., designs and sells wireless broadband networking infrastructure products and services globally. The company operates with a workforce of approximately 486 employees across 25 countries, with significant international operations and sales. Manufacturing is outsourced to third-party providers primarily located outside the U.S., including countries such as Vietnam and Thailand, which exposes the company to risks related to tariffs, trade regulations, and supply chain disruptions. Cambium Networks relies heavily on a limited number of distributors for sales, which impacts demand visibility and revenue predictability. The company has faced challenges including product shipment delays, quality control issues, and component shortages. Financially, Cambium Networks reported a net loss and liquidity constraints as of the fiscal year ended December 31, 2025. The company was delisted from Nasdaq in March 2026 and currently trades on the OTC Expert Market, which has reduced liquidity and market visibility. Cambium Networks is undertaking cost reduction initiatives and working with lenders to address defaults under its Credit Agreement, which matures in late 2026. The company emphasizes innovation, ethical business practices, and employee development as core to its culture.

iRhythm Holdings, Inc. designs, develops, and commercializes device-based technology for ambulatory cardiac monitoring (ACM) services. Its core product offerings combine a wire-free, patch-based, 14-day wearable biosensor with proprietary cloud-based analytic software to continuously record and analyze electrocardiogram (ECG) data. The company provides long-term continuous monitoring (LTCM) and mobile cardiac telemetry (MCT) services primarily for patients suspected of having infrequent or asymptomatic arrhythmias. iRhythm operates Medicare-enrolled independent diagnostic testing facilities (IDTFs) staffed with qualified technicians who validate data and notify physicians of clinically actionable arrhythmias. The company has delivered over twelve million patient reports and holds approximately 40% penetration of the U.S. ambulatory cardiac monitoring market. It targets cardiology, electrophysiology, primary care, and other specialties, focusing on integrated delivery networks and risk-bearing entities. iRhythm has expanded its presence internationally through direct sales and distributor relationships in the UK, Europe, and Japan. The company emphasizes physician education, clinical evidence publication, and electronic health record (EHR) integration to support adoption and clinical workflow integration. Its proprietary FDA-cleared deep learning algorithms analyze ECG data, with reports accessible via the ZioSuite portal and mobile apps. The company reported a net loss of $13.9 million for Q1 2026 and maintains strong liquidity with a current ratio of 5.17 as of March 31, 2026.

DexCom, Inc. develops and commercializes continuous glucose monitoring (CGM) systems designed to help patients, caregivers, and clinicians manage diabetes and metabolic health. The company markets its products globally through a combination of direct sales and distribution partnerships. Its product portfolio includes the Dexcom G7 CGM system and the Stelo biosensor, the latter targeting adults with prediabetes and Type 2 diabetes who do not use insulin. DexCom generates revenue primarily from disposable sensors and reusable hardware components. The company invests in research and development to enhance its sensing technology and expand applications beyond glucose monitoring, including metabolic health insights and other patient populations.

FiEE, Inc. is a digital service provider that completed a business transformation in 2025, moving away from its legacy networking hardware business. Its current operations focus on integrating artificial intelligence and data analytics into digital content services, software development, and digital authentication. The company ceased its legacy operations by the end of 2025 and launched its new business model, generating $6.2 million in service fees and achieving profitability in that year. FiEE pursues growth through acquisitions, including a recent majority equity investment and convertible loan in a Chinese cultural company. The company operates in a competitive and rapidly evolving market with significant regulatory and operational risks.

FibroBiologics, Inc. is a Delaware-based biotechnology company focused on developing fibroblast-based cell therapy products. The company operates primarily through research and development of its product candidates, which are manufactured via third-party contract development and manufacturing organizations (CDMOs). FibroBiologics has encountered manufacturing challenges, including process issues and low yields, which have impacted clinical trial timelines, particularly for its CYWC628 candidate targeting diabetic foot ulcers. The company reported a net loss and negative cash flows, with liquidity supported by recent equity offerings and cost reduction initiatives. FibroBiologics maintains a board of directors with experienced leadership, including its founder and CEO Pete O'Heeron. The company has recently secured new patents and actively participates in industry conferences. It is listed on the Nasdaq Capital Market and has addressed prior listing compliance issues.

Prologis, Inc. operates as a self-managed REIT specializing in logistics real estate, with a global footprint spanning 20 countries and four continents. The company’s portfolio includes approximately 1.3 billion square feet of logistics and data center properties, managed both on a wholly owned and co-investment basis. Prologis’s business is organized into two segments: Real Estate, which includes rental operations and development of logistics and data center facilities, and Strategic Capital, which involves partnerships with institutional investors through co-investment ventures. The Real Estate segment generates the majority of revenues through long-term leases with fixed or inflation-linked escalations, serving a broad and diversified customer base including major logistics and retail companies. Development activities focus on modern, sustainable facilities and selective data center projects, leveraging strategic locations and access to power. The Strategic Capital segment provides asset and property management services and generates management fees and promote revenues, primarily outside the U.S. Prologis emphasizes sustainability through solar energy projects and ESG integration. The company maintains a strong balance sheet with conservative leverage, significant liquidity, and a long average debt maturity profile. Foreign currency and interest rate risks are actively managed through hedging and borrowing strategies. Recent developments include a dividend increase and a focus on data center growth.

Cullen/Frost Bankers, Inc. operates as a financial holding company headquartered in San Antonio, Texas, serving primarily Texas markets. Its business includes commercial and consumer banking, trust and investment management, insurance, brokerage, mutual funds, leasing, treasury management, capital markets advisory, and item processing. The company manages a diversified loan portfolio and maintains liquidity through a mix of liquid assets and access to wholesale funding. It actively manages capital through stock repurchase programs and pays dividends on common and preferred stock. Governance structures include dedicated cybersecurity oversight committees reporting to the board. The company regularly discloses financial results and risk factors in SEC filings.

Cable One, Inc. is a broadband services provider operating primarily through its subsidiary MBI, which offers broadband, fiber connectivity, video, and voice services to residential and commercial customers under the Vyve Broadband brand. The company currently owns approximately 45% of MBI and has entered into a definitive agreement to acquire the remaining 55%, subject to regulatory approvals and customary closing conditions. The acquisition involves a purchase price based on MBI's adjusted EBITDA and net indebtedness, with financing planned through cash and debt facilities. Cable One reported solid liquidity metrics as of March 31, 2026, including $165.6 million in cash and a current ratio of 1.75. The company reported net income of $35.8 million and basic EPS of $6.29 for Q1 2026. Recent news and filings highlight leadership changes, including a new CEO and independent chair, and a merger involving Clearwave Fiber LLC, a joint venture in which Cable One holds an interest. The company faces risks typical of the sector, including competition, technology evolution, regulatory approvals, integration of acquisitions, and cybersecurity threats.

Coursera, Inc. is a Delaware public benefit corporation and Certified B Corporation that provides an online learning platform connecting learners, content creators, and enterprise customers. The platform offers a broad portfolio of educational content, including open online courses, certificates, and degree programs developed in collaboration with academic institutions and other content creators. Revenue is generated through subscriptions, content fees, and tuition shares. The company serves both individual learners and enterprise customers globally, with a focus on expanding offerings, scaling technology, and growing its learner and customer base. Coursera faces a competitive and rapidly evolving market landscape, including emerging AI technologies and new entrants. The company is currently pursuing a merger with Udemy, which involves customary regulatory and execution risks. Coursera's financials reflect ongoing investments in growth and platform development, with net losses continuing in recent periods. The company maintains a strong liquidity position as of Q1 2026.

OneSpan Inc. is a Delaware-incorporated company headquartered in Boston, Massachusetts, publicly traded on NASDAQ under the ticker OSPN. The company operates in the digital identity and anti-fraud solutions sector, providing products and services to its customers. As of the quarter ended March 31, 2026, OneSpan reported $49.75 million in cash and cash equivalents and $122.88 million in current assets against $98.00 million in current liabilities, resulting in a current ratio of 1.25 and a cash ratio of 1.53, indicating a solid liquidity position. The company reported net income of $11.57 million for Q1 2026 with basic and diluted earnings per share of $0.31 and $0.30 respectively. OneSpan has a $100 million revolving credit facility established in June 2025 with MUFG Bank, maturing in 2030, with no borrowings outstanding as of that date. The company regularly communicates financial results and operational updates through earnings call transcripts and press releases, with recent coverage spanning from Q3 2024 through Q1 2026.

Royal Caribbean Cruises Ltd. is a leading global cruise vacation company operating three main brands—Royal Caribbean, Celebrity Cruises, and Silversea—plus a 50% interest in TUI Cruises. The company offers a broad range of cruise vacations targeting multiple market segments from contemporary family to ultra-luxury and expedition travel. Its fleet includes 69 ships with plans for new ship deliveries and expansion of private destinations. The company emphasizes innovation, technology integration, environmental sustainability, and customer engagement to enhance its competitive position in the global vacation industry. It competes with other major cruise lines and land-based vacation alternatives. The company maintains a focus on cost efficiency, capital allocation, and liquidity management while investing in fleet upgrades and new vessels.

ASGN Inc is a technology and digital engineering company providing IT solutions to commercial and government clients primarily in the United States. The company operates under two segments: Commercial and Federal Government. The Commercial Segment serves Fortune 1000 and large mid-market clients across six solution areas and five industries, offering consulting, creative digital marketing, and permanent placement services. The Federal Government Segment delivers advanced IT solutions in data and AI, cybersecurity, software engineering, and enterprise platforms to defense, intelligence, national security, and other federal agencies. ASGN has a broad talent pool of approximately 19,600 billable professionals and 2,800 internal employees. The company leverages proprietary assets, accelerators, and strategic partnerships with leading technology providers to deliver tailored IT solutions. ASGN's business model emphasizes higher-value consulting services with enhanced margin opportunities and a unique delivery model that provides cost advantages and flexibility. The company maintains a significant contract backlog and a diversified client base, with no single client other than the U.S. federal government representing more than 10% of revenues.

Cerus Corporation is a medical technology company specializing in blood safety products. The company’s business model centers on developing and commercializing technologies that reduce the risk of transfusion-transmitted infections. Cerus generates revenue primarily through product sales, with recent disclosures indicating growth in product revenue. The company maintains liquidity with a current ratio above 1.6 and cash reserves exceeding $27 million as of Q1 2026. Executive leadership changes and compensation structures have been recently updated, reflecting governance and retention strategies. No legal proceedings are currently reported.

Summit Therapeutics Inc. is a biopharmaceutical company specializing in oncology drug development. Its lead candidate, ivonescimab, is a bispecific antibody designed to block PD-1 and VEGF pathways simultaneously, potentially enhancing antitumor activity. The company has licensed global rights to ivonescimab from Akeso, covering the US, Canada, Europe, Japan, Latin America, Middle East, and Africa. Summit is conducting multiple Phase III clinical trials targeting various NSCLC patient populations and colorectal cancer. The HARMONi trial showed significant progression-free survival benefits and positive overall survival trends, supporting the FDA's acceptance of the BLA. Summit's operations focus on clinical development, regulatory submissions, and preparing for potential commercialization. The company has incurred significant losses and depends on external funding to sustain operations. Manufacturing is outsourced, primarily to Akeso, with associated operational risks.

RIOT PLATFORMS INC operates within the Financial Services sector, specifically in Capital Markets. The company reported $167.2 million in revenue for Q1 2026 but incurred a net loss of $500.5 million during the same period. As of March 31, 2026, it held $205.7 million in cash and equivalents and maintained a current ratio of 1.08, indicating modest liquidity. The company has engaged in stock repurchases and secured a $200 million credit facility with Coinbase Credit, Inc. Recent developments highlight its focus on AI data center infrastructure and strategic growth initiatives.

Rivian is an American automotive technology company that designs, manufactures, and sells electric vehicles and related software and services. Its consumer vehicle lineup includes the R1T pickup and R1S SUV, with plans to expand into midsize vehicles such as the R2 SUV and R3 crossover. The company also produces commercial electric delivery vans in partnership with Amazon, which has placed a large order. Rivian's vehicles incorporate proprietary technologies including a zonal network electrical architecture, an AI-driven autonomy platform, and cloud-enabled over-the-air software updates. The company sells vehicles directly to consumers and commercial customers in the U.S. and is expanding its charging infrastructure. Rivian operates in a highly competitive market with established automakers and faces challenges related to production scaling, supply chain, regulatory environment, and capital requirements.

TruGolf Holdings, Inc. is a virtual golf technology company headquartered in Utah, USA. It develops and markets golf simulation products and services, including hardware and software solutions. The company is led by CEO Christopher Jones, who has a background in video game development and has been with the company since its inception. TruGolf's product portfolio includes the portable LaunchBox launch monitor and AI-enhanced golf coaching technologies. The company is expanding its franchising operations with new locations and franchisees. Financial disclosures indicate revenues of approximately $4.11 million for the first nine months of 2025 and a net loss of about $15.23 million for the full year 2025. Liquidity ratios as of December 31, 2025, show a current ratio of 1.07 and a cash ratio of 0.9, reflecting near parity between current assets and liabilities.

Expion360 Inc. operates in the energy storage sector, focusing on home energy storage solutions. The company is publicly traded on The Nasdaq Capital Market under the ticker XPON and is classified as an emerging growth company. In 2025, Expion360 launched its e360 Home Energy Storage Solutions and reported significant revenue growth in the first two quarters of 2025, with 111% year-over-year growth in Q1 and 134% growth in Q2. The company completed a $2.6 million direct offering and private placement with institutional investors in early 2025 and has an At-The-Market Issuance Sales Agreement for up to $15 million in common stock sales. Leadership transitions occurred in 2025, with Joseph Hammer appointed CEO and Chairman, Shawna Bowin as CFO, and Carson Heagen as COO. The company reported full year 2025 revenue of approximately $9.65 million and a net loss of about $6.24 million, with liquidity ratios indicating strong short-term financial health as of December 31, 2025.

Estrella Immunopharma, Inc. is a Delaware-based emerging growth biopharmaceutical company specializing in cancer immunotherapy drug development. The company is led by Dr. Cheng Liu, an experienced scientist and inventor in antibody drug discovery, supported by a board with diverse expertise. Estrella is advancing its clinical pipeline, notably the STARLIGHT-1 Phase I/II trial for EB103, which has progressed to Phase II. The company has engaged in capital raising activities including a $100 million stock and warrants offering. Financially, Estrella reported a net loss for fiscal 2025 and has a low current ratio, reflecting liquidity challenges. The company is actively addressing Nasdaq listing compliance issues and has established governance policies including related party transaction oversight.

Data I/O Corporation designs, manufactures, and sells programming and security deployment systems for flash memory, microcontrollers, and security integrated circuits. Its products serve electronics manufacturers in automotive, IoT, industrial, medical, wireless, and consumer electronics sectors. The company operates manufacturing and engineering facilities in the US and China, with sales and support in Germany. In 2025, under new leadership, Data I/O executed a strategic transformation to modernize its go-to-market approach, invest in technology, strengthen customer relationships, optimize operations, and deploy AI. A key strategic shift is expanding from a narrow offline semiconductor programming equipment market to the broader data provisioning market, including programming, configuration, and testing across the manufacturing lifecycle and emerging Edge AI applications. The company also formed a collaboration with IAR to simplify secure device provisioning across global supply chains. The business model is evolving to increase recurring revenues from consumables, software services, and programming-at-test offerings, reducing reliance on cyclical capital equipment sales and the automotive sector. The company reported $21.5 million in revenue for 2025, with consumables and services comprising 58% of revenue. Bookings declined 17% in 2025, with regional variations in demand. The company maintains a strong balance sheet with $7.9 million cash and no debt at year-end 2025. A targeted cyber incident in August 2025 led to system shutdowns and highlighted cybersecurity risks. Management is actively pursuing operational efficiencies and inorganic growth opportunities aligned with its strategic direction [S1][S2].

Syntec Optics Holdings, Inc. operates in the optics and photonics sector, developing and manufacturing advanced optical components and systems for defense, biomedical, and consumer applications. The company has expanded through acquisitions and product innovation, offering solutions such as high-performance fuel actuators for rocket propulsion, night vision optics, satellite optomechanicals, and direct-to-eye projection technologies for AR/VR/MR devices. Syntec Optics also pursues applications in commercial fusion energy and drug discovery through photonic biosensing technologies. The company is controlled by founder and CEO Al Kapoor, who has a strong background in optics industry leadership and capital markets. The Board includes independent directors with expertise in finance, operations, and M&A. Syntec Optics is an emerging growth company listed on Nasdaq and has recently raised capital through a public offering. The company has faced operational challenges including losses from labor costs and consumer demand weakness but has taken steps to improve margins and reduce costs.

Columbia Financial, Inc. operates as a bank holding company headquartered in Fair Lawn, New Jersey, with Columbia Bank as its primary subsidiary. The company is publicly traded on Nasdaq under the ticker CLBK. It focuses on regional banking services and has a board of directors with diverse expertise in banking, law, operations, accounting, and government. The company maintains a comprehensive executive compensation program that includes base salary, short-term incentives, and long-term equity awards. Columbia Financial has engaged in strategic growth activities, including a merger announcement with Northfield Bancorp in early 2026. The company files detailed annual and quarterly reports with the SEC, providing transparency into its financial condition and governance.

SBC Medical Group Holdings Inc is a healthcare-focused company providing management consulting and operational support services to medical corporations and clinics, including cosmetic surgery and other specialized medical services. The company operates under a structured fee agreement with its medical corporation clients, offering services ranging from marketing and medical safety to human resources and IT management. The company’s leadership includes experienced executives with backgrounds in healthcare management and corporate development. The board of directors includes independent members and oversees risk management and compensation. Financially, the company reported solid liquidity and profitability as of the end of 2025, with ongoing strategic initiatives to focus on core business areas.

Health Catalyst, Inc. provides healthcare data analytics and technology solutions aimed at improving clinical, financial, and operational outcomes for healthcare organizations. The company offers a platform with analytics applications and tech-enabled managed services to support population health management, care coordination, and healthcare consulting. Health Catalyst has expanded through acquisitions and focuses on innovation to meet evolving client needs in a competitive and rapidly changing healthcare market. The company operates with a recurring revenue model and emphasizes professional services and client support to maintain and grow its client base.

374Water Inc. develops and commercializes AirSCWO technology, a supercritical water oxidation process designed for the destruction of hazardous waste streams, including PFAS contaminants. The company operates primarily in the environmental technology sector, focusing on waste treatment solutions that address emerging regulatory and public health concerns. Its technology has been deployed in government projects such as the Department of Defense's ESTCP program and in partnerships with municipal sanitation districts. The company is headquartered in Morrisville, North Carolina, and trades on the Nasdaq Capital Market under the ticker SCWO. Leadership includes experienced executives with backgrounds in technology, operations, and finance. The Board comprises a mix of independent directors and company insiders, including the technology inventor and co-founder. Financially, the company reported modest revenue in 2025 alongside a net loss, with liquidity ratios indicating sufficient short-term asset coverage of liabilities. The company continues to focus on commercializing its technology and expanding its market footprint in environmental remediation [S1][N3][N6][N7].

Fluent, Inc. operates as a commerce media solutions provider, delivering customer acquisition services through digital marketing campaigns. The company accesses consumers via its Commerce Media Solutions marketplace, which embeds proprietary ad-serving technology on partner sites and mobile apps, and through its owned and operated digital media properties (O&O Sites) that attract users primarily via promotional offers. Fluent collects first-party user data with consent to enable targeted advertising and provides clients with contact information for direct communication. The company also operates a call center-supported performance marketplace focused on live call-based campaigns, particularly in the health insurance sector. Revenue is primarily generated on a performance basis, including per click, lead, or action, aligning with client acquisition cost targets. Commerce Media Solutions operates under exclusive long-term contracts with media partners, remunerated mainly on a revenue share basis, with limited media inventory risk. Fluent's wholly owned subsidiary, AdParlor, offers managed services for creator marketing and media buying on social platforms. The company faces challenges from regulatory requirements, media supply volatility, and macroeconomic conditions, which have impacted revenue and profitability.

Mediaco Holding Inc. is a media company incorporated in Indiana with principal offices in New York. It operates through subsidiaries and has acquired assets from Estrella Broadcasting. The company’s common stock trades on Nasdaq under the symbol MDIA. Mediaco’s business includes media content distribution and partnerships, exemplified by its strategic partnership between EstrellaTV and EVTV Digital Network. The company has entered into credit agreements to finance acquisitions and operations, including first and second lien term loans. Leadership changes have occurred recently, including the appointment of Alberto Rodriguez as CEO. The company is classified as a smaller reporting company and an emerging growth company, with governance involving designated board members from controlling shareholders and investment affiliates.

Fermi Inc. is a development-stage company engaged in the development of Project Matador, a large-scale infrastructure initiative combining nuclear power, natural gas, solar energy, and data center operations. The company has not yet constructed its facilities or secured binding tenant contracts, and it has no operating history or revenue. Project Matador involves complex permitting, financing, and construction challenges. The company relies on third-party suppliers and contractors for its operations. Fermi's leadership team recently underwent significant changes, including the removal of its CEO and appointment of an Interim CFO. The company reported a net loss and maintains a substantial cash position as of the end of 2025.